545 related articles for article (PubMed ID: 27223281)
1. Circulating MicroRNAs as Biomarkers in Biliary Tract Cancers.
Letelier P; Riquelme I; Hernández AH; Guzmán N; Farías JG; Roa JC
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27223281
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA markers for the diagnosis of pancreatic and biliary-tract cancers.
Kojima M; Sudo H; Kawauchi J; Takizawa S; Kondou S; Nobumasa H; Ochiai A
PLoS One; 2015; 10(2):e0118220. PubMed ID: 25706130
[TBL] [Abstract][Full Text] [Related]
3. Identification of potential biomarkers for diagnosis of pancreatic and biliary tract cancers by sequencing of serum microRNAs.
Kim K; Yoo D; Lee HS; Lee KJ; Park SB; Kim C; Jo JH; Jung DE; Song SY
BMC Med Genomics; 2019 May; 12(1):62. PubMed ID: 31096984
[TBL] [Abstract][Full Text] [Related]
4. Genetic alteration regulated by microRNAs in biliary tract cancers.
Wang N; Xia S; Chen K; Xiang X; Zhu A
Crit Rev Oncol Hematol; 2015 Nov; 96(2):262-73. PubMed ID: 26095617
[TBL] [Abstract][Full Text] [Related]
5. Circulating microRNAs as diagnostic and prognostic tools for hepatocellular carcinoma.
Zhang YC; Xu Z; Zhang TF; Wang YL
World J Gastroenterol; 2015 Sep; 21(34):9853-62. PubMed ID: 26379392
[TBL] [Abstract][Full Text] [Related]
6. Clinical impact of bile-derived exosomal microRNAs as novel diagnostic and prognostic biomarkers for biliary tract cancers.
Yoshida M; Yukawa H; Hayashi K; Naitoh I; Miyabe K; Hori Y; Natsume M; Jinno N; Kato A; Kachi K; Asano G; Sahashi H; Toyohara T; Kuno K; Kito Y; Kondo H; Hirano A; Okumura F; Anbe K; Baba Y; Kataoka H; Tanaka Y
Cancer Sci; 2023 Jan; 114(1):295-305. PubMed ID: 36168845
[TBL] [Abstract][Full Text] [Related]
7. Real-time PCR-based analysis of the human bile microRNAome identifies miR-9 as a potential diagnostic biomarker for biliary tract cancer.
Shigehara K; Yokomuro S; Ishibashi O; Mizuguchi Y; Arima Y; Kawahigashi Y; Kanda T; Akagi I; Tajiri T; Yoshida H; Takizawa T; Uchida E
PLoS One; 2011; 6(8):e23584. PubMed ID: 21858175
[TBL] [Abstract][Full Text] [Related]
8. Circulating microRNAs: potential biomarkers for common malignancies.
Khoury S; Tran N
Biomark Med; 2015; 9(2):131-51. PubMed ID: 25689901
[TBL] [Abstract][Full Text] [Related]
9. Plasma miR-21 is a novel diagnostic biomarker for biliary tract cancer.
Kishimoto T; Eguchi H; Nagano H; Kobayashi S; Akita H; Hama N; Wada H; Kawamoto K; Tomokuni A; Tomimaru Y; Umeshita K; Doki Y; Mori M
Cancer Sci; 2013 Dec; 104(12):1626-31. PubMed ID: 24118467
[TBL] [Abstract][Full Text] [Related]
10. Circulating Cancer Biomarkers: The Macro-revolution of the Micro-RNA.
Montani F; Bianchi F
EBioMedicine; 2016 Mar; 5():4-6. PubMed ID: 27077096
[TBL] [Abstract][Full Text] [Related]
11. The role of circulating miRNAs in multiple myeloma.
Zhang J; Xiao X; Liu J
Sci China Life Sci; 2015 Dec; 58(12):1262-9. PubMed ID: 26607481
[TBL] [Abstract][Full Text] [Related]
12. Circulating miRNAs in cancer: from detection to therapy.
Wang WT; Chen YQ
J Hematol Oncol; 2014 Dec; 7():86. PubMed ID: 25476853
[TBL] [Abstract][Full Text] [Related]
13. Plasma microRNA192 in combination with serum CA19-9 as non-invasive prognostic biomarker in periampullary carcinoma.
Murali Manohar K; Sasikala M; Kvsrr Y; Sunil V; Talukdar R; Murthy H; Ramji C; Rao GV; Pradeep R; Reddy DN
Tumour Biol; 2017 Mar; 39(3):1010428317695018. PubMed ID: 28351309
[TBL] [Abstract][Full Text] [Related]
14. Clinical relevance of circulating cell-free microRNAs in ovarian cancer.
Nakamura K; Sawada K; Yoshimura A; Kinose Y; Nakatsuka E; Kimura T
Mol Cancer; 2016 Jun; 15(1):48. PubMed ID: 27343009
[TBL] [Abstract][Full Text] [Related]
15. Serum microRNAs as potential noninvasive biomarkers for glioma.
Yu X; Li Z
Tumour Biol; 2016 Feb; 37(2):1407-10. PubMed ID: 26628296
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs role as potential biomarkers and key regulators in melanoma.
Varamo C; Occelli M; Vivenza D; Merlano M; Lo Nigro C
Genes Chromosomes Cancer; 2017 Jan; 56(1):3-10. PubMed ID: 27561079
[TBL] [Abstract][Full Text] [Related]
17. Translating microRNAs into biomarkers: What is new for pediatric cancer?
de Carvalho IN; de Freitas RM; Vargas FR
Med Oncol; 2016 May; 33(5):49. PubMed ID: 27085875
[TBL] [Abstract][Full Text] [Related]
18. Circulating MicroRNAs: A Next-Generation Clinical Biomarker for Digestive System Cancers.
Kawaguchi T; Komatsu S; Ichikawa D; Tsujiura M; Takeshita H; Hirajima S; Miyamae M; Okajima W; Ohashi T; Imamura T; Kiuchi J; Konishi H; Shiozaki A; Okamoto K; Otsuji E
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27598137
[TBL] [Abstract][Full Text] [Related]
19. Deregulated MicroRNAs in Biliary Tract Cancer: Functional Targets and Potential Biomarkers.
Mayr C; Beyreis M; Wagner A; Pichler M; Neureiter D; Kiesslich T
Biomed Res Int; 2016; 2016():4805270. PubMed ID: 27957497
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of circulating miRNA detection in lung cancer.
Zhao C; Lu F; Chen H; Zhao F; Zhu Z; Zhao X; Chen H
Med Oncol; 2016 May; 33(5):41. PubMed ID: 27034265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
